株探米国株
英語
エドガーで原本を確認する
6-K 1 d908504d6k.htm 6-K 6-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

Form 6-K

 

 

Report of Foreign Private Issuer

Pursuant to Rule 13a-16 or 15d-16

Under the Securities Exchange Act of 1934

For the month of February, 2025

Commission File Number: 001-38336

 

 

NUTRIEN LTD.

(Name of registrant)

 

 

Suite 1700, 211 19th Street East

Saskatoon, Saskatchewan, Canada

S7K 5R6

(Address of principal executive office)

 

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F ☐   Form 40-F ☒

 

 

 


SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    NUTRIEN LTD.
Date: February 19, 2025     By:  

/s/ Noralee Bradley

    Name:   Noralee Bradley
    Title:   Executive Vice President, External Affairs and Chief Sustainability and Legal Officer


EXHIBIT INDEX

 

Exhibit   

Description of Exhibit

99.1    News Release dated February 19, 2025
EX-99.1 2 d908504dex991.htm EX-99.1 EX-99.1

Exhibit 99.1

 

LOGO    News Release

 

TSX, NYSE: NTR

 

February 19, 2025 – all amounts are in US dollars, except as otherwise noted

 

Nutrien Reports Fourth Quarter and Full-Year 2024 Results

 

 

Full-year results demonstrate significant progress towards strategic priorities and 2026 performance targets.

 

 

 

2025 guidance reflects expectation for continued growth in upstream fertilizer volumes, higher downstream Retail earnings and lower capital expenditures.

 

SASKATOON, Saskatchewan - Nutrien Ltd. (TSX and NYSE: NTR) announced today its fourth quarter 2024 results, with net earnings of $118 million ($0.23 diluted net earnings per share). Fourth quarter 2024 adjusted EBITDA1 was $1.1 billion and adjusted net earnings per share1 was $0.31.

“Nutrien delivered higher upstream fertilizer sales volumes, accelerated operational efficiency and cost savings initiatives and increased downstream Retail earnings in 2024, demonstrating significant progress towards our 2026 performance targets. We took a disciplined and intentional approach to our capital allocation decisions, further optimizing capital expenditures and returning $1.2 billion to shareholders through dividends and share repurchases,” commented Ken Seitz, Nutrien’s President and CEO.

“The outlook for our business in 2025 is supported by expectations for strong crop input demand and firming potash fundamentals. Nutrien has a world-class asset base, and we remain focused on strategic priorities that strengthen our core business and deliver structural improvements to our earnings and free cash flow,” added Mr. Seitz.

Highlights2:

 

 

Generated net earnings of $700 million ($1.36 diluted net earnings per share) and adjusted EBITDA of $5.4 billion ($3.47 adjusted net earnings per share) for the full year of 2024.

 

 

Retail adjusted EBITDA increased to $1.7 billion in 2024 supported by higher product margins and lower expenses, as we continue to simplify our business and accelerate downstream network optimization initiatives.

 

 

Potash adjusted EBITDA decreased to $1.8 billion in 2024 as lower net selling prices more than offset increased sales volumes. We mined 35 percent of our potash ore tonnes using automation in 2024, providing efficiency, flexibility and safety benefits, while supporting our highest annual production levels on record and a reduction in controllable cash cost of product manufactured per tonne.

 

 

Nitrogen adjusted EBITDA of $1.9 billion in 2024 was relatively flat as lower net selling prices offset higher sales volumes and lower natural gas costs. Total ammonia production increased in 2024, driven by less maintenance downtime and improved natural gas utilization and reliability at our operations in Trinidad.

 

 

Divested non-core assets and equity investments totaling approximately $60 million in 2024, providing incremental cash flow to allocate to high conviction priorities that are core to our long-term strategy.

 

 

Repurchased 3.9 million shares for a total of $190 million in the second half of 2024 and an additional 1.9 million shares in 2025 for $96 million as of February 18, 2025. Nutrien’s Board of Directors approved the purchase of up to 5 percent of Nutrien’s outstanding common shares over a twelve-month period through the renewal of our normal course issuer bid (“NCIB”), which is subject to acceptance by the Toronto Stock Exchange.

 

 

Nutrien’s Board of Directors approved an increase in the quarterly dividend to $0.545 per share. Nutrien continues to target a stable and growing dividend, having now increased the dividend per share by 36 percent since the beginning of 2018.

1. This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

2. Our discussion of highlights set out on this page is a comparison of the results for the twelve months ended December 31, 2024 to the results for the twelve months ended December 31, 2023, unless otherwise noted.

 

1


Market Outlook and Guidance

Agriculture and Retail Markets

 

 

Global grain stocks-to-use ratios remain historically low and demand remains strong, providing a supportive environment for ag commodity prices in 2025. We expect US corn plantings to range between 91 and 93 million acres and soybean plantings to range from 84 to 86 million acres in 2025. The projected increase in corn acreage, combined with a shortened fall application season in 2024, supports our outlook for strong North American fertilizer demand in the first half of the year.

 

 

In Brazil, generally favorable soil moisture conditions and stronger crop prices are expected to lead to an increase in safrinha corn planted acreage of approximately five percent, supporting crop input demand in the first half of 2025.

 

 

A weaker Australian dollar and strong grain and oilseed export demand is supporting grower economics, and conditions remain positive for 2025 crop input demand.

Crop Nutrient Markets

 

 

Global potash shipments rebounded to approximately 72.5 million tonnes in 2024, driven by improved supply and supportive application economics that contributed to increased demand in key markets such as China, Brazil and Southeast Asia.

 

 

We forecast global potash shipments between 71 and 75 million tonnes in 2025. The high end of the range captures the potential for stronger underlying global consumption and the lower end captures the potential for reduced supply availability. We anticipate the potential for supply tightness with limited global capacity additions in 2025 and reported operational challenges and maintenance work in key producing regions.

 

 

Global urea and UAN prices have increased in the first quarter of 2025, driven by strengthening demand in key import markets and restricted supply, including continued Chinese urea export restrictions. Global ammonia prices have trended lower to start the year due to seasonal demand weakness and the anticipation of incremental supply in the US and export capacity from Russia. We expect North American natural gas prices to remain highly competitive compared to Europe and Asia, with Henry Hub natural gas prices projected to average between $3.25 and $3.50 per MMBtu for the year.

 

 

The US nitrogen supply and demand balance is expected to be tight ahead of the spring application season, as nitrogen fertilizer net imports in the first half of the 2024/2025 fertilizer year were down approximately 60 percent compared to the five-year average. Additionally, nitrogen demand for the spring season is expected to be strong due to the limited fall ammonia application season and higher projected corn acreage.

 

 

Phosphate fertilizer markets remain firm, particularly in North America where inventories were estimated to be historically low entering 2025. We expect Chinese phosphate exports similar to 2024 levels, with total DAP/MAP exports ranging between 6 and 7 million tonnes, and tight stocks in India to support demand ahead of their key planting season.

Financial and Operational Guidance

 

 

Retail adjusted EBITDA guidance of $1.65 to $1.85 billion assumes higher crop nutrient sales volumes, continued growth of our proprietary products and further margin recovery in Brazil. We anticipate foreign exchange headwinds in our international retail operations and the absence of asset sales and other income items realized in 2024, which combined are estimated at approximately $75 million.

 

 

Potash sales volume guidance of 13.6 to 14.4 million tonnes is consistent with our global shipments outlook and accounts for some uncertainty regarding the possible imposition and related impact of US tariffs, as well as global supply availability.

 

 

Nitrogen sales volume guidance of 10.7 to 11.2 million tonnes assumes continued reliability improvements and higher operating rates at our North American plants.

 

 

Phosphate sales volume guidance of 2.35 to 2.55 million tonnes assumes lower production at our White Springs facility in the first half of 2025 and improved operating rates in the second half compared to the prior year.

 

 

Total capital expenditures of $2.0 to $2.1 billion are expected to be lower than the prior year. Our capital expenditure program has been further optimized to sustain safe and reliable operations and to progress a set of targeted growth investments. This total includes approximately $400 to $500 million in investing capital expenditures focused on proprietary products, network optimization and digital capabilities in Retail, low-cost brownfield expansions in Nitrogen and mine automation projects in Potash.

 

2


All guidance numbers, including those noted above, are outlined in the table below. In addition, set forth below are anticipated fertilizer pricing and natural gas price sensitivities relating to adjusted EBITDA (consolidated) and adjusted net earnings per share.

 

   

2025 Guidance Ranges 1 as of

February 19, 2025

        
 (billions of US dollars, except as otherwise noted)   Low     High     2024 Actual   

 Retail adjusted EBITDA

    1.65       1.85       1.7   

 Potash sales volumes (million tonnes) 2

    13.6       14.4       13.9   

 Nitrogen sales volumes (million tonnes) 2

    10.7       11.2       10.7   

 Phosphate sales volumes (million tonnes) 2

    2.35       2.55       2.4   

 Depreciation and amortization

    2.35       2.45       2.3   

 Finance costs

    0.65       0.75       0.7   

 Effective tax rate on adjusted net earnings (%) 3

    22.0       25.0       24.1   

 Capital expenditures 4

    2.0       2.1       2.2   

1  See the “Forward-Looking Statements” section.

2  Manufactured product only.

3  This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

4  Comprised of sustaining capital expenditures, investing capital expenditures and mine development and pre-stripping capital expenditures, which are supplementary financial measures. See the “Other Financial Measures” section.

 

 2025 Annual Sensitivities 1   Effect on  
 (millions of US dollars, except EPS amounts)   Adjusted EBITDA     Adjusted EPS 4   

 $25 per tonne change in potash net selling prices

       ±280        ±0.45   

 $25 per tonne change in ammonia net selling prices 2

       ± 35        ±0.05   

 $25 per tonne change in urea and ESN® net selling prices

       ± 85        ±0.15   

 $25 per tonne change in solutions, nitrates and sulfates net selling prices

       ±130        ±0.20   

 $1 per MMBtu change in NYMEX natural gas price 3

       ±190        ±0.30   

1  See the “Forward-Looking Statements” section.

2  Includes related impact on natural gas costs in Trinidad, which is linked to benchmark ammonia pricing.

3  Nitrogen related impact.

4  Assumes 486 million shares outstanding for all earnings per share (“EPS”) sensitivities.

 

3


Consolidated Results

 

     Three Months Ended December 31            Twelve Months Ended December 31  

(millions of US dollars, except as otherwise noted)

      2024        2023       % Change               2024        2023       % Change  

Sales

     5,079        5,664        (10        25,972        29,056        (11

Gross margin

     1,581        1,768        (11        7,530        8,474        (11

Expenses

     1,184        1,475        (20        5,674        5,729        (1

Net earnings

     118        176        (33        700        1,282        (45

Adjusted EBITDA 1

     1,055        1,075        (2        5,355        6,058        (12

Diluted net earnings per share (US dollars)

     0.23        0.35        (34        1.36        2.53        (46

Adjusted net earnings per share (US dollars) 1

     0.31        0.37        (16        3.47        4.44        (22

1  This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

Net earnings and adjusted EBITDA decreased in the fourth quarter of 2024 compared to the same period in 2023, primarily due to lower Potash net selling prices and sales volumes, partially offset by higher Retail earnings and lower expenses. For the full year of 2024, net earnings and adjusted EBITDA decreased compared to 2023 due to lower Potash and Nitrogen net selling prices, partially offset by increased Retail earnings and record Potash sales volumes. Net earnings were also impacted by a previously disclosed loss on foreign currency derivatives in the second quarter of 2024.

Segment Results

Our discussion of segment results set out on the following pages is a comparison of the results for the three and twelve months ended December 31, 2024 to the results for the three and twelve months ended December 31, 2023, unless otherwise noted.

 

 Nutrien Ag Solutions (“Retail”)

 

 

     Three Months Ended December 31            Twelve Months Ended December 31  

(millions of US dollars, except as otherwise noted)

      2024        2023       % Change               2024        2023       % Change  

Sales

     3,179        3,502        (9        17,832        19,542        (9

Cost of goods sold

     2,193        2,513        (13        13,211        15,112        (13

Gross margin

     986        989        -          4,621        4,430        4  

Adjusted EBITDA 1

     340        229        48          1,696        1,459        16  

1  See Note 2 to the unaudited condensed consolidated financial statements as at and for the three and twelve months ended December 31, 2024 (“interim financial statements”).

 

 

Retail adjusted EBITDA increased in the fourth quarter of 2024 due to lower expenses and higher crop protection and seed margins, including increased proprietary products gross margins and improved margins and selling expenses in Brazil. During the fourth quarter, we recognized a $25 million gain on the sale of land in Argentina as we continue to simplify our business. Adjusted EBITDA increased for the full year, supported by higher product margins in all geographies and lower expenses.

 

     Three Months Ended December 31             Twelve Months Ended December 31  
     Sales           Gross Margin             Sales           Gross Margin  
 (millions of US dollars)      2024         2023              2024         2023                2024         2023              2024         2023   

 Crop nutrients

     1,528         1,808            294         346            7,211         8,379            1,444         1,378   

 Crop protection products

     948         960            351         333            6,313         6,750            1,622         1,553   

 Seed

     184         202            52         36            2,235         2,295            431         427   

 Services and other

     228         236            188         188            918         927            716         710   

 Merchandise

     230         251            40         41            897         1,001            150         172   

 Nutrien Financial

     77         70            77         70            361         322            361         322   

 Nutrien Financial elimination 1

     (16)        (25)           (16)        (25)           (103)        (132)           (103)        (132)  

 Total

     3,179         3,502            986         989            17,832         19,542            4,621         4,430   

1  Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

 

4


 

Crop nutrients sales decreased in the fourth quarter of 2024 due to lower sales volumes, which were impacted by wet weather in North America and strategic actions related to our margin improvement plan in Brazil. Full-year 2024 sales were impacted by lower selling prices and sales volumes. Gross margin decreased in the fourth quarter as higher per-tonne margins in North America were more than offset by lower sales volumes. For the full year, gross margin increased due to higher per-tonne margins in North America, including growth in our proprietary crop nutritional and biostimulant product lines.

 

 

Crop protection products sales were lower in the fourth quarter and full year of 2024 mainly due to lower selling prices. Gross margin improvements for the fourth quarter and full year of 2024 were supported by proprietary products, strong operational execution and the selling through of lower cost inventory in South America compared to the same periods in 2023.

 

 

Seed sales decreased in the fourth quarter and full year of 2024 mainly due to the impact of competitive pricing pressure in South America. Gross margin for the fourth quarter increased, supported by higher proprietary gross margin, including improved margins in South America due to strategic actions related to our margin improvement plan in Brazil. Full-year 2024 gross margin increased as improved margins in North America more than offset the impact of dry weather and competitive market pressures in Brazil.

 

 

Merchandise sales and gross margin decreased in the fourth quarter and full year of 2024 due to reductions in Australia primarily related to weather-related impacts on water equipment sales and animal health products.

 

 

Nutrien Financial sales and gross margin increased in the fourth quarter and full year of 2024 due to higher financing rates offered.

 

 Supplemental Data    Three Months Ended December 31             Twelve Months Ended December 31  
     Gross Margin           % of Product Line 1             Gross Margin           % of Product Line 1  

 (millions of US dollars, except

  as otherwise noted)

     2024         2023              2024         2023                2024         2023              2024         2023   

 Proprietary products

                                

Crop nutrients

     60         44            19         12            421         391            29         28   

Crop protection products

     41         27            11         10            470         461            29         30   

Seed

     6         (3)           16         (9)           154         168            36         39   

Merchandise

     4         3            9         6            15         11            10         6   

Total

     111         71            11         8            1,060         1,031            23         23   

 1  Represents percentage of proprietary product margins over total product line gross margin.

   

                 
     Three Months Ended December 31             Twelve Months Ended December 31  
    

Sales Volumes

(tonnes - thousands)

         

Gross Margin / Tonne

(US dollars)

           

Sales Volumes

(tonnes - thousands)

         

Gross Margin / Tonne

(US dollars)

 
        2024         2023              2024         2023                2024         2023              2024         2023   

 Crop nutrients

                                

North America

     1,854         2,073            125         118            8,547         8,985            142         127   

International

     716         790            87         127            3,715         3,647            62         65   

Total

     2,570         2,863            114         120            12,262         12,632            118         109   

 

 (percentages)    December 31, 2024              December 31, 2023   

 Financial performance measures 1, 2

        

Cash operating coverage ratio

     63            68   

Adjusted average working capital to sales

     20            19   

Adjusted average working capital to sales excluding Nutrien Financial

     -            1   

Nutrien Financial adjusted net interest margin

     5.3            5.2   

1  Rolling four quarters.

2  These are non-GAAP financial measures. See the “Non-GAAP Financial Measures” section.

 

5


 

 Potash

 

 

 

     Three Months Ended December 31           Twelve Months Ended December 31  
 (millions of US dollars, except as otherwise noted)      2024         2023       % Change             2024         2023       % Change  

 Net sales

     536         776         (31         2,989         3,759         (20

 Cost of goods sold

     309         349         (11         1,448         1,396         4  

 Gross margin

     227         427         (47         1,541         2,363         (35

 Adjusted EBITDA 1

     291         463         (37         1,848         2,404         (23

1  See Note 2 to the interim financial statements.

 

 

Potash adjusted EBITDA decreased in the fourth quarter of 2024 due to lower net selling prices and sales volumes. Full-year 2024 adjusted EBITDA was lower mainly due to lower net selling prices, partially offset by record sales volumes. Higher potash production supported by the continued advancement of mine automation contributed to our lower controllable cash cost of product manufactured for the full year of 2024.

 

Manufactured Product    Three Months Ended
December 31
            Twelve Months Ended
December 31
 
($ / tonne, except as otherwise noted)       2024         2023                2024         2023  

Sales volumes (tonnes - thousands)

              

North America

     718        1,089           4,672        4,843  

Offshore

     2,040        2,214           9,214        8,373  

Total sales volumes

     2,758        3,303           13,886        13,216  

Net selling price

              

North America

     270        342           285        348  

Offshore

     168        182           180        248  

Average net selling price

     194        235           215        284  

Cost of goods sold

     112        106           104        105  

Gross margin

     82        129           111        179  

Depreciation and amortization

     49        36           44        35  

Gross margin excluding depreciation and amortization 1

     131        165           155        214  

1  This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

 

 

Sales volumes decreased in the fourth quarter of 2024 compared to the record volumes delivered in the same period in the prior year due to a more restricted fall application window in North America and lower volumes to China and Other Asian markets. Full-year 2024 sales volumes were the highest on record, supported by low channel inventories and strong potash affordability in North America and key offshore markets.

 

 

Net selling price per tonne decreased in the fourth quarter and full year of 2024 primarily due to a decline in benchmark prices compared to the same periods in 2023.

 

 

Cost of goods sold per tonne increased in the fourth quarter of 2024 as higher depreciation and the impact of more planned turnaround activity more than offset lower royalties. For the full year, cost of goods sold per tonne decreased primarily due to higher production volumes and lower royalties, partially offset by higher depreciation.

 

Supplemental Data    Three Months Ended
December 31
            Twelve Months Ended
December 31
 
         2024         2023                2024         2023  

Production volumes (tonnes – thousands)

     3,369        3,386           14,205        12,998  

Potash controllable cash cost of product manufactured per tonne 1

     59        56           54        58  

Canpotex sales by market (percentage of sales volumes)

              

Latin America

     35        32           40        47  

Other Asian markets 2

     24        28           28        28  

China

     16        19           13        9  

India

     11        11           7        5  

Other markets

     14        10           12        11  

Total

     100        100           100        100  

1  This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

2  All Asian markets except China and India.

 

6


 Nitrogen

 

 

    Three Months Ended December 31          Twelve Months Ended December 31  
(millions of US dollars, except as otherwise noted)      2024        2023       % Change             2024       2023       % Change  

Net sales

    1,013       956       6          3,745       4,207       (11

Cost of goods sold

    700       671       4          2,535       2,828       (10

Gross margin

    313       285       10          1,210       1,379       (12

Adjusted EBITDA 1

    471       391       20          1,884       1,930       (2

1  See Note 2 to the interim financial statements.

 

 

Nitrogen adjusted EBITDA increased in the fourth quarter of 2024 primarily due to higher sales volumes and ammonia net selling prices. Adjusted EBITDA for the full year was relatively flat as lower net selling prices offset higher sales volumes and lower natural gas costs. Our total ammonia production increased in the fourth quarter and full year supported by less maintenance downtime and improved natural gas utilization and reliability at our operations in Trinidad.

 

Manufactured Product   Three Months Ended
December 31
         Twelve Months Ended
December 31
 
($ / tonne, except as otherwise noted)      2024        2023             2024        2023  

Sales volumes (tonnes - thousands)

          

Ammonia

    701       651          2,483       2,436  

Urea and ESN®

    888       739          3,188       3,125  

Solutions, nitrates and sulfates

    1,325       1,344          5,023       4,862  

Total sales volumes

    2,914       2,734          10,694       10,423  

Net selling price

          

Ammonia

    448       416          410       469  

Urea and ESN®

    403       428          421       480  

Solutions, nitrates and sulfates

    213       215          221       244  

Average net selling price

    327       321          324       367  

Cost of goods sold

    221       218          213       233  

Gross margin

    106       103          111       134  

Depreciation and amortization

    58       53          55       55  

Gross margin excluding depreciation and amortization 1

    164       156          166       189  

1  This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

 

 

Sales volumes increased in the fourth quarter due to higher urea production and strong regional demand for ammonia. Full-year 2024 sales volumes increased due to higher production at our operations in Trinidad and reliability improvements across our network in North America increasing the availability of upgraded products.

 

 

Net selling price per tonne was higher in the fourth quarter of 2024 primarily due to stronger ammonia net selling prices and a favorable geographic mix. For the full year, net selling price per tonne was lower for all major nitrogen products due to weaker benchmark prices.

 

 

Cost of goods sold per tonne increased in the fourth quarter of 2024 mainly due to higher natural gas costs in Trinidad, partially offset by lower natural gas costs in North America. For the full year, cost of goods sold per tonne decreased primarily due to lower natural gas costs in North America and the impact of higher production volumes.

 

Supplemental Data

   
Three Months Ended
December 31

 
      
Twelve Months Ended
December 31

 
         2024          2023             2024          2023  

Sales volumes (tonnes – thousands)

          

Fertilizer

    1,801       1,648          6,259       6,067  

Industrial and feed

    1,113       1,086          4,435       4,356  

Production volumes (tonnes – thousands)

          

Ammonia production – total 1

    1,451       1,362          5,608       5,357  

Ammonia production – adjusted 1, 2

    1,041       1,022          3,953       3,902  

Ammonia operating rate (%) 2

    92       91          88       88  

Natural gas costs (US dollars per MMBtu)

          

Overall natural gas cost excluding realized derivative impact

    3.61       3.35          3.15       3.51  

Realized derivative impact 3

    0.10       (0.05        0.09       (0.02

Overall natural gas cost

    3.71       3.30          3.24       3.49  

1  All figures are provided on a gross production basis in thousands of product tonnes.

2  Excludes Trinidad and Joffre.

3  Includes realized derivative impacts recorded as part of cost of goods sold or other income and expenses. Refer to Note 4 to the interim financial statements.

 

7


 Phosphate

 

 

     Three Months Ended December 31          Twelve Months Ended December 31  

(millions of US dollars, except as otherwise noted)

        2024           2023          % Change             2024           2023          % Change  

Net sales

     414        533        (22        1,657        1,993        (17

Cost of goods sold

     394        463        (15        1,510        1,760        (14

Gross margin

     20        70        (71        147        233        (37

Adjusted EBITDA 1

     86        130        (34        384        470        (18

1  See Note 2 to the interim financial statements.

 

 

Phosphate adjusted EBITDA was lower in the fourth quarter of 2024 as higher net selling prices were more than offset by the impact of lower production volumes and higher input costs. Adjusted EBITDA for the full year decreased due to weaker industrial and feed net selling prices and the impact of lower production, partially offset by lower sulfur and ammonia input costs.

 

Manufactured Product    Three Months Ended
December 31
          Twelve Months Ended
December 31
 

($ / tonne, except as otherwise noted)

        2024           2023              2024           2023  

Sales volumes (tonnes - thousands)

              

Fertilizer

     435        579           1,751        1,912  

Industrial and feed

     173        174           683        639  

Total sales volumes

     608        753           2,434        2,551  

Net selling price

              

Fertilizer

     615        557           612        568  

Industrial and feed

     812        860           822        1,010  

Average net selling price

     671        627           671        678  

Cost of goods sold

     631        535           603        583  

Gross margin

     40        92           68        95  

Depreciation and amortization

     127        108           119        115  

Gross margin excluding depreciation and amortization 1

     167        200           187        210  

1  This is a non-GAAP financial measure. See the “Non-GAAP Financial Measures” section.

 

 

Sales volumes were lower in the fourth quarter and full year primarily due to weather-related events and plant outages that impacted production volumes.

 

 

Net selling price per tonne increased in the fourth quarter of 2024 primarily due to the strength of fertilizer benchmark prices. For the full year of 2024, net selling price per tonne decreased due to lower industrial and feed net selling prices which reflect the typical lag in price realizations relative to benchmark prices.

 

 

Cost of goods sold per tonne increased in the fourth quarter of 2024 due to lower production volumes, higher depreciation, and higher input costs, including sulfur. Full-year cost of goods sold per tonne increased due to lower production volumes and higher water treatment costs related to weather-related events, partially offset by lower sulfur and ammonia input costs.

 

Supplemental Data    Three Months Ended
December 31
            Twelve Months Ended
December 31
 
          2024           2023              2024           2023  

Production volumes (P2O5 tonnes – thousands)

     319        380           1,327        1,406  

P2O5  operating rate (%)

     75        89           78        83  

 

8


 Corporate and Others and Eliminations

 

 

    Three Months Ended December 31           Twelve Months Ended December 31  

(millions of US dollars, except as otherwise noted)

      2024       2023       % Change           2024       2023       % Change  

Corporate and Others

             

Gross margin 1

    13       -       n/m         13       -       n/m  

Selling expenses

    7       7       -         -       -       -  

General and administrative expenses

    126       104       21         403       364       11  

Share-based compensation expense (recovery)

    20       (7     n/m         37       (14     n/m  

Foreign exchange loss (income), net of related derivatives

    1       (14     n/m         360       91       296  

Other expenses

     105       175       (40       379       257       47  

Adjusted EBITDA 1

    (160     (117     37         (456     (267      71  

Eliminations

             

Gross margin

    22       (3     n/m         (2     69       n/m  

Adjusted EBITDA 1

    27       (21     n/m         (1     62       n/m  

1  See Note 2 to the interim financial statements.

 

 

Share-based compensation was an expense in the fourth quarter and full year of 2024 due to an increase in the fair value of our share-based awards. We had a recovery in the same periods in 2023 as the fair value of our share-based awards decreased. The fair value of our share-based awards takes into consideration several factors such as our share price movement, our performance relative to our peer group and our return on invested capital.

 

 

Foreign exchange loss, net of related derivatives was higher in the full year of 2024 compared to the same period in 2023 as it included a previously disclosed $220 million loss on foreign currency derivatives in Brazil.

 

 

Other expenses were lower in the fourth quarter of 2024 compared to the same period in 2023 mainly due to a lower expense for asset retirement obligations and accrued environmental costs related to our non-operating sites partially offset by higher restructuring costs. Other expenses in the full year of 2024 were higher compared to the same period in 2023 due to an $80 million gain in the full year of 2023 from our other post-retirement benefit plan amendments. These were partially offset by lower losses related to our financial instruments in Argentina. Refer to Note 4 of the interim financial statements for additional information.

 

 

Eliminations of gross margin in the full year of 2024 resulted from higher intersegment inventory held by our Retail segment compared to a recovery of gross margin in the full year of 2023, which reflected the sell-through of higher cost inventory.

Finance Costs, Income Taxes and Other Comprehensive Income (Loss)

 

    Three Months Ended December 31           Twelve Months Ended December 31  

(millions of US dollars, except as otherwise noted)

      2024       2023       % Change           2024       2023       % Change  

Finance costs

    195       213       (8       720       793       (9

Income taxes

             

Income tax expense (recovery)

    84       (96     n/m          436         670        (35

Actual effective tax rate including discrete items (%)

    42       (120     n/m         38       34       12  

Other comprehensive (loss) income

    (298     97       n/m         (234     81       n/m  

 

 

Finance costs were lower in the fourth quarter and full year of 2024 primarily due to lower average short-term debt balance from lower working capital requirements, partially offset by the increase in average long-term debt balance throughout 2024.

 

 

Income tax was an expense in the fourth quarter of 2024 compared to a recovery in the same period in 2023 mainly due to higher earnings and lower discrete tax adjustments. In the fourth quarter of 2023, our discrete tax items included a $134 million income tax recovery due to changes in our tax declarations in Switzerland (“Swiss Tax Reform”). These factors resulted in a positive effective tax rate in the fourth quarter of 2024 compared to a negative effective tax rate in the same period in 2023.

 

9


The lower income tax expense in the full year of 2024 compared to the same period in 2023 was due to lower earnings and lower discrete tax adjustments. The discrete tax adjustments in the same period in 2023 were related to a change in recognition of deferred tax assets in South America as they no longer met the asset recognition criteria, the impact of the Swiss Tax Reform, and Canadian audit assessments.

 

 

Other comprehensive loss in the fourth quarter and full year of 2024 was mainly due to the depreciation of the Australian, Brazilian and Canadian currencies, relative to the US dollar, compared to gains for the same periods in 2023.

Forward-Looking Statements

Certain statements and other information included in this document, including within the “Market Outlook and Guidance” section, constitute “forward-looking information” or “forward-looking statements” (collectively, “forward-looking statements”) under applicable securities laws (such statements are often accompanied by words such as “anticipate”, “forecast”, “expect”, “believe”, “may”, “will”, “should”, “estimate”, “project”, “intend” or other similar words). All statements in this document, other than those relating to historical information or current conditions, are forward-looking statements, including, but not limited to:

Nutrien’s business strategies, plans, prospects and opportunities; Nutrien’s 2025 full-year guidance, including expectations regarding Retail adjusted EBITDA, Potash sales volumes, Nitrogen sales volumes, Phosphate sales volumes, depreciation and amortization, finance costs, effective tax rate on adjusted net earnings and capital expenditures, including the assumptions and expectations stated therein; our 2026 performance targets; expectations regarding our capital allocation intentions and strategies, including our target of providing a stable and growing dividend; our ability to advance strategic priorities that strengthen our core business and deliver structural improvements to our earnings and free cash flow; capital spending expectations for 2025 and beyond, including the expectation that related investments will sustain safe and reliable operations and drive growth; expectations regarding performance of our operating segments in 2025 and beyond; our operating segment market outlooks and our expectations for market conditions and fundamentals, and the anticipated supply and demand for our products and services, expected market, industry and growing conditions with respect to crop nutrient application rates, planted acres, farmer crop investment, crop mix, including the need to replenish soil nutrient levels, production volumes and expenses, shipments, natural gas costs and availability, consumption, prices, operating rates and the impact of seasonality, import and export volumes, tariffs, trade or export restrictions, economic sanctions and restrictions, operating rates, inventories, crop development and natural gas curtailments; the negotiation of sales contracts; acquisitions and divestitures and the anticipated benefits thereof; and expectations in connection with our ability to deliver long-term returns to shareholders.

These forward-looking statements are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control, which could cause actual results to differ materially from such forward-looking statements. As such, undue reliance should not be placed on these forward-looking statements.

All of the forward-looking statements are qualified by the assumptions that are stated or inherent in such forward-looking statements, including the assumptions referred to below and elsewhere in this document. Although we believe that these assumptions are reasonable, having regard to our experience and our perception of historical trends, this list is not exhaustive of the factors that may affect any of the forward-looking statements and the reader should not place undue reliance on these assumptions and such forward-looking statements. Current conditions, economic and otherwise, render assumptions, although reasonable when made, subject to greater uncertainty.

The additional key assumptions that have been made in relation to the operation of our business as currently planned and our ability to achieve our business objectives include, among other things, assumptions with respect to: our ability to successfully implement our business strategies, growth and capital allocation investments and initiatives that we will conduct our operations and achieve results of operations as anticipated; our ability to successfully complete, integrate and realize the anticipated benefits of our already completed and future acquisitions and divestitures, and that we will be able to implement our standards, controls, procedures and policies in respect of any acquired businesses and to realize the expected synergies on the anticipated timeline or at all; that future business, regulatory and industry conditions will be within the parameters expected by us, including with respect to prices, expenses, margins, demand, supply, product availability, shipments, consumption, weather conditions, supplier agreements, product distribution agreements, inventory levels, exports, tariffs, including general or retaliatory tariffs, trade restrictions, international trade arrangements, crop development and cost of labor and interest, exchange and effective tax rates; potash demand growth in offshore markets and normalization of Canpotex port operations; global economic conditions and the accuracy of our market outlook expectations for 2025 and in the future; assumptions related to our assessment of recoverable amount estimates of our assets, including in relation to our Retail - Brazil business asset impairments; our intention to complete share repurchases under our normal course issuer bid programs, the funding of such share repurchases, existing and future market conditions, including with respect to the price of our common shares, capital allocation priorities and compliance with respect to applicable limitations under securities laws and regulations and stock exchange policies and assumptions related to our ability to fund our dividends at the current level; our expectations regarding the impacts, direct and indirect, of certain geopolitical conflicts, including the war in Eastern Europe and the conflict in the Middle East on, among other things, global supply and demand, including for crop nutrients, energy and commodity prices, global interest rates, supply chains and the global macroeconomic environment, including inflation; the adequacy of our cash generated from operations and our ability to access our credit facilities or capital markets for additional sources of financing; our ability to identify suitable candidates for acquisitions and divestitures and negotiate acceptable terms; availability of investment opportunities that align with our strategic priorities and growth strategy; our ability to maintain investment grade ratings and achieve our performance targets; and our ability to successfully negotiate sales and other contracts and our ability to successfully implement new initiatives and programs.

 

10


Events or circumstances that could cause actual results to differ materially from those in the forward-looking statements include, but are not limited to: general global economic, market and business conditions; failure to achieve expected results of our business strategy, capital allocation initiatives, results of operations or targets, such as our targeted $200 million in annual consolidated cost savings, expected capital expenditures in 2025, delivering upstream fertilizer sales volume growth and advancing high-return downstream Retail growth opportunities; failure to complete announced and future acquisitions or divestitures at all or on the expected terms and within the expected timeline; seasonality; climate change and weather conditions, including impacts from regional flooding and/or drought conditions; crop planted acreage, yield and prices; the supply and demand and price levels for our products; governmental and regulatory requirements and actions by governmental authorities, including changes in government policy (including general or retaliatory tariffs, trade restrictions, including the imposition of any tariffs, or other changes to international trade arrangements; the effects of current and future multinational trade agreements or other developments affecting the level of trade or export restrictions and climate change initiatives), government ownership requirements, changes in environmental, tax, antitrust and other laws or regulations and the interpretation thereof; political or military risks, including civil unrest, actions by armed groups or conflict and malicious acts including terrorism and industrial espionage; our ability to access sufficient, cost-effective and timely transportation, distribution and storage of products (including potential rail transportation and port disruptions due to labor strikes and/or work stoppages or other similar actions); the occurrence of a major environmental or safety incident or becoming subject to legal or regulatory proceedings; innovation and cybersecurity risks related to our systems, including our costs of addressing or mitigating such risks; counterparty and sovereign risk; delays in completion of turnarounds at our major facilities or challenges related to our major facilities that are out of our control; interruptions of or constraints in availability of key inputs, including natural gas and sulfur; any significant impairment of the carrying amount of certain assets; the risk that rising interest rates and/or deteriorated business operating results may result in the further impairment of assets or goodwill attributed to certain of our cash generating units; risks related to reputational loss; certain complications that may arise in our mining processes; the ability to attract, engage and retain skilled employees and strikes or other forms of work stoppages; geopolitical conflicts, including the war in Eastern Europe and the conflict in the Middle East, and their potential impact on, among other things, global market conditions and supply and demand, including for crop nutrients, energy and commodity prices, interest rates, supply chains and the global economy generally; our ability to execute on our strategies related to environmental, social and governance matters, and achieve related expectations, targets and commitments, including risks associated with disclosure thereof; and other risk factors detailed from time to time in Nutrien reports filed with the Canadian securities regulators and the SEC.

The purpose of our revised Retail adjusted EBITDA and our depreciation and amortization, finance costs, effective tax rate and capital expenditures guidance ranges are to assist readers in understanding our expected and targeted financial results, and this information may not be appropriate for other purposes.

The forward-looking statements in this document are made as of the date hereof and Nutrien disclaims any intention or obligation to update or revise any forward-looking statements in this document as a result of new information or future events, except as may be required under applicable Canadian securities legislation or applicable US federal securities laws.

Terms and Definitions

For the definitions of certain financial and non-financial terms used in this document, as well as a list of abbreviated company names and sources, see the “Terms and definitions” section of our 2023 Annual Report. All references to per share amounts pertain to diluted net earnings (loss) per share, “n/m” indicates information that is not meaningful, and all financial amounts are stated in millions of US dollars, unless otherwise noted.

 

11


About Nutrien

Nutrien is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers. We focus on creating long-term value by prioritizing investments that strengthen the advantages of our business across the ag value chain and by maintaining access to the resources and the relationships with stakeholders needed to achieve our goals.

For Further Information:

Jeff Holzman

Vice President, Investor Relations

(306) 933-8545

Investors@nutrien.com

More information about Nutrien can be found at www.nutrien.com.

Selected financial data for download can be found in our data tool at www.nutrien.com/investors/interactive-datatool

Such data is not incorporated by reference herein.

 

 

Nutrien will host a Conference Call on Thursday, February 20, 2025 at 10:00 a.m. Eastern Time.

Telephone conference dial-in numbers:

 

 

From Canada and the US: 1 (800) 206-4400

 

International: 1 (289) 514-5005

 

No access code required. Please dial in 15 minutes prior to ensure you are placed on the call in a timely manner.

Live Audio Webcast: Visit https://www.nutrien.com/news/events/2024-q4-earnings-conference-call We use both IFRS measures and certain non-GAAP financial measures to assess performance.

 

12


Non-GAAP Financial Measures

Non-GAAP financial measures are financial measures disclosed by the Company that: (a) depict historical or expected future financial performance, financial position or cash flow of the Company; (b) with respect to their composition, exclude amounts that are included in, or include amounts that are excluded from, the composition of the most directly comparable financial measure disclosed in the primary financial statements of the Company; (c) are not disclosed in the financial statements of the Company; and (d) are not a ratio, fraction, percentage or similar representation. Non-GAAP ratios are financial measures disclosed by the Company that are in the form of a ratio, fraction, percentage or similar representation that has a non-GAAP financial measure as one or more of its components, and that are not disclosed in the financial statements of the Company.

These non-GAAP financial measures and non-GAAP ratios are not standardized financial measures under IFRS and, therefore, are unlikely to be comparable to similar financial measures presented by other companies. Management believes these non-GAAP financial measures and non-GAAP ratios provide transparent and useful supplemental information to help investors evaluate our financial performance, financial condition and liquidity using the same measures as management. These non-GAAP financial measures and non-GAAP ratios should not be considered as a substitute for, or superior to, measures of financial performance prepared in accordance with IFRS.

The following section outlines our non-GAAP financial measures and non-GAAP ratios, their compositions, and why management uses each measure. It also includes reconciliations to the most directly comparable IFRS measures. Except as otherwise described herein, our non-GAAP financial measures and non-GAAP ratios are calculated on a consistent basis from period to period and are adjusted for specific items in each period, as applicable. As additional non-recurring or unusual items arise in the future, we generally exclude these items in our calculations.

Adjusted EBITDA (Consolidated)

Most directly comparable IFRS financial measure: Net earnings (loss).

Definition: Adjusted EBITDA is calculated as net earnings (loss) before finance costs, income taxes, depreciation and amortization, share-based compensation and foreign exchange gain/loss (net of related derivatives). We also adjust this measure for the following other income and expenses that are excluded when management evaluates the performance of our day-to-day operations: integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on disposal of certain businesses and investments, asset retirement obligations (“ARO”) and accrued environmental costs (“ERL”) related to our non-operating sites, and loss related to financial instruments in Argentina.

Why we use the measure and why it is useful to investors: It is not impacted by long-term investment and financing decisions, but rather focuses on the performance of our day-to-day operations. It provides a measure of our ability to service debt and to meet other payment obligations and as a component of employee remuneration calculations.

 

     Three Months Ended December 31      Twelve Months Ended December 31  

 (millions of US dollars)

          2024             2023             2024            2023  

 Net earnings

     118        176        700       1,282  

 Finance costs

     195        213        720       793  

 Income tax expense (recovery)

     84        (96      436       670  

 Depreciation and amortization

     590        565        2,339       2,169  

 EBITDA 1

     987        858        4,195       4,914  

 Adjustments:

          

Share-based compensation expense (recovery)

     20        (7      37       (14

Foreign exchange loss (gain), net of related derivatives

     1        (14      360       91  

ARO/ERL related (income) expenses for non-operating sites

     (1      142        151       152  

Loss related to financial instruments in Argentina

     1        -        35       92  

Restructuring costs

     47        20        47       49  

Impairment of assets

     -        76        530       774  

 Adjusted EBITDA

     1,055        1,075        5,355       6,058  

1  EBITDA is calculated as net earnings before finance costs, income taxes, and depreciation and amortization.

 

13


Adjusted Net Earnings and Adjusted Net Earnings Per Share

Most directly comparable IFRS financial measure: Net earnings (loss) and diluted net earnings (loss) per share.

Definition: Adjusted net earnings and related per share information are calculated as net earnings (loss) before share-based compensation and foreign exchange gain/loss (net of related derivatives), net of tax. We also adjust this measure for the following other income and expenses (net of tax) that are excluded when management evaluates the performance of our day-to-day operations: certain integration and restructuring related costs, impairment or reversal of impairment of assets, gain or loss on disposal of certain businesses and investments, gain or loss on early extinguishment of debt or on settlement of derivatives due to discontinuance of hedge accounting, asset retirement obligations and accrued environmental costs related to our non-operating sites, loss related to financial instruments in Argentina, change in recognition of tax losses and deductible temporary differences related to impairments and certain changes to tax declarations. We generally apply the annual forecasted effective tax rate to specific adjustments during the year, and at year-end, we apply the actual effective tax rate.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations and is used as a component of employee remuneration calculations.

 

    

Three Months Ended

December 31, 2024

   

Twelve Months Ended

December 31, 2024

 

 (millions of US dollars, except as otherwise noted)

    
Increases
(Decreases)
 
 
         Post-Tax      

Per
  Diluted
Share
 
 
 
   
Increases
(Decreases)
 
 
         Post-Tax      

Per
  Diluted
Share
 
 
 

 Net earnings attributable to equity holders of Nutrien

          113       0.23            674       1.36  

 Adjustments:

                                                          

Share-based compensation expense

     20          15       0.03       37          27       0.05  

Foreign exchange (gain) loss, net of related derivatives

     1          (16     (0.03     360          346       0.70  

Restructuring costs

     47          38       0.08       47          38       0.08  

Impairment of assets

     -          -       -       530          492       1.00  

ARO/ERL related (income) expenses for non-operating sites

     (1        (1     -       151          106       0.21  

Loss related to financial instruments in Argentina

     1          1       -       35          35       0.07  

Sub-total adjustments

     68            37       0.08       1,160            1,044       2.11  
                 

 Adjusted net earnings

                  150       0.31                    1,718       3.47  
    

Three Months Ended

December 31, 2023

   

Twelve Months Ended

December 31, 2023

 

 (millions of US dollars, except as otherwise noted)

    
Increases
(Decreases)
 
 
         Post-Tax      

Per
  Diluted
Share
 
 
 
   
Increases
(Decreases)
 
 
         Post-Tax      

Per
  Diluted
Share
 
 
 

 Net earnings attributable to equity holders of Nutrien

          172       0.35            1,258       2.53  

 Adjustments:

                                                          

Share-based compensation recovery

     (7        (5     (0.01     (14        (11     (0.02

Foreign exchange (gain) loss, net of related derivatives

     (14        (16     (0.03     91          83       0.17  

Restructuring costs

     20          16       0.03       49          40       0.08  

Impairment of assets

     76          49       0.10       774          702       1.42  

ARO/ERL related expenses for non-operating sites

     142          102       0.20       152          110       0.22  

Loss related to financial instruments in Argentina

     -          -       -       92          92       0.18  

Swiss Tax Reform adjustment

     (134        (134     (0.27     (134        (134     (0.27

Change in recognition of deferred tax assets

     -          -       -       66          66       0.13  

Sub-total adjustments

     83            12       0.02       1,076            948       1.91  
                 

 Adjusted net earnings

                  184       0.37                    2,206       4.44  

 

14


Effective Tax Rate on Adjusted Net Earnings

Effective tax rate on adjusted net earnings guidance is a forward-looking non-GAAP financial measure as it includes adjusted net earnings, which is a non-GAAP financial measure. It is provided to assist readers in understanding our expected financial results. Effective tax rate on adjusted net earnings guidance excludes certain items that management is aware of that permit management to focus on the performance of our operations (see the Adjusted Net Earnings and Adjusted Net Earnings Per Share section for items generally adjusted). We do not provide a reconciliation of this forward-looking measure to the most directly comparable financial measures calculated and presented in accordance with IFRS because a meaningful or accurate calculation of reconciling items and the information is not available without unreasonable effort due to unknown variables, including the timing and amount of certain reconciling items, and the uncertainty related to future results. These unknown variables may include unpredictable transactions of significant value that may be inherently difficult to determine without unreasonable efforts. The probable significance of such unavailable information, which could be material to future results, cannot be addressed.

Effective tax rate on adjusted net earnings ratio is calculated as adjusted income tax expense divided by adjusted earnings before income taxes. We use this measure to provide the actual result for a previously disclosed forward-looking effective tax rate on adjusted net earnings guidance.

 

 (millions of US dollars, except as otherwise noted)

         2024   

 Earnings before income taxes

    1,136   

 Adjustments 1

    1,160   

 Adjusted earnings before income taxes

    2,296   

 Income tax expense

    436   

 Adjustments 2

    116   

 Adjusted income tax expense

    552   

 Effective tax rate on adjusted net earnings (%)

    24.1   

1  Calculated as sum of pre-tax adjustments noted in the Adjusted Net Earnings section.

2  Calculated as difference between the sum of pre-tax and post-tax adjustments noted in the Adjusted Net Earnings section.

Gross Margin Excluding Depreciation and Amortization Per Tonne – Manufactured Product

Most directly comparable IFRS financial measure: Gross margin.

Definition: Gross margin per tonne less depreciation and amortization per tonne for manufactured products. Reconciliations are provided in the “Segment Results” section.

Why we use the measure and why it is useful to investors: Focuses on the performance of our day-to-day operations, which excludes the effects of items that primarily reflect the impact of long-term investment and financing decisions.

Potash Controllable Cash Cost of Product Manufactured (“COPM”) Per Tonne

Most directly comparable IFRS financial measure: Cost of goods sold (“COGS”) for the Potash segment.

Definition: Total Potash COGS excluding depreciation and amortization expense included in COPM, royalties, natural gas costs and carbon taxes, change in inventory, and other adjustments, divided by potash production tonnes.

Why we use the measure and why it is useful to investors: To assess operational performance. Potash controllable cash COPM excludes the effects of production from other periods and the impacts of our long-term investment decisions, supporting a focus on the performance of our day-to-day operations. Potash controllable cash COPM also excludes royalties and natural gas costs and carbon taxes, which management does not consider controllable, as they are primarily driven by regulatory and market conditions.

 

15


      Three Months Ended December 31        Twelve Months Ended December 31   

 (millions of US dollars, except as otherwise noted)

          2024             2023             2024             2023  

 Total COGS – Potash

     309        349        1,448        1,396  

 Change in inventory

     66        7        36        (40

 Other adjustments 1

     (7      (7      (21      (26

 COPM

     368        349        1,463        1,330  

 Depreciation and amortization in COPM

     (142      (124      (581      (427

 Royalties in COPM

     (17      (23      (79      (100

 Natural gas costs and carbon taxes in COPM

     (9      (12      (36      (46

 Controllable cash COPM

     200        190        767        757  

 Production tonnes (tonnes – thousands)

     3,369        3,386        14,205        12,998  

 Potash controllable cash COPM per tonne

     59        56        54        58  

1  Other adjustments include unallocated production overhead that is recognized as part of cost of goods sold but is not included in the measurement of inventory and changes in inventory balances.

Nutrien Financial Adjusted Net Interest Margin

Definition: Nutrien Financial revenue less deemed interest expense divided by average Nutrien Financial net receivables outstanding for the last four rolling quarters.

Why we use the measure and why it is useful to investors: Used by credit rating agencies and others to evaluate the financial performance of Nutrien Financial.

 

    Rolling four quarters ended December 31, 2024  
 (millions of US dollars, except as otherwise noted)   Q1 2024     Q2 2024     Q3 2024     Q4 2024      Total/Average   

 Nutrien Financial revenue

    66       133       85       77    

 Deemed interest expense 1

    (27     (50     (52     (45        

 Net interest

    39       83       33       32       187   

 Average Nutrien Financial net receivables

    2,489       4,560       4,318       2,877       3,561   

 Nutrien Financial adjusted net interest margin (%)

                                    5.3   
    Rolling four quarters ended December 31, 2023  
 (millions of US dollars, except as otherwise noted)   Q1 2023     Q2 2023     Q3 2023     Q4 2023      Total/Average   

 Nutrien Financial revenue

    57       122       73       70    

 Deemed interest expense 1

    (20     (39     (41     (36        

 Net interest

    37       83       32       34       186   

 Average Nutrien Financial net receivables

    2,283       4,716       4,353       2,893       3,561   

 Nutrien Financial adjusted net interest margin (%)

                                    5.2   

1  Average borrowing rate applied to the notional debt required to fund the portfolio of receivables from customers monitored and serviced by Nutrien Financial.

 

16


Retail Cash Operating Coverage Ratio

Definition: Retail selling, general and administrative, and other expenses (income), excluding depreciation and amortization expense, divided by Retail gross margin excluding depreciation and amortization expense in cost of goods sold, for the last four rolling quarters.

Why we use the measure and why it is useful to investors: To understand the costs and underlying economics of our Retail operations and to assess our Retail operating performance and ability to generate cash flow.

 

    Rolling four quarters ended December 31, 2024  
 (millions of US dollars, except as otherwise noted)   Q1 2024     Q2 2024     Q3 2024     Q4 2024          Total  

 Selling expenses

      790         1,005       815       808       3,418  

 General and administrative expenses

    52       51       51       37       191  

 Other expenses

    22       41       32       (8     87  

 Operating expenses

    864       1,097       898       837       3,696  

 Depreciation and amortization in operating expenses

    (190     (193     (182     (186     (751

 Operating expenses excluding depreciation and amortization

    674       904       716       651       2,945  

 Gross margin

    747       2,029       859       986       4,621  

 Depreciation and amortization in cost of goods sold

    4       3       8       5       20  

 Gross margin excluding depreciation and amortization

    751       2,032       867       991       4,641  

 Cash operating coverage ratio (%)

                                    63  
    Rolling four quarters ended December 31, 2023  
 (millions of US dollars, except as otherwise noted)   Q1 2023     Q2 2023     Q3 2023     Q4 2023     Total  

 Selling expenses

    765       971       798       841       3,375  

 General and administrative expenses

    50       55       57       55       217  

 Other expenses

    15       29       37       77       158  

 Operating expenses

    830       1,055       892       973       3,750  

 Depreciation and amortization in operating expenses

    (179     (185     (186     (199     (749

 Operating expenses excluding depreciation and amortization

    651       870       706       774       3,001  

 Gross margin

    615       1,931       895       989       4,430  

 Depreciation and amortization in cost of goods sold

    2       3       3       2       10  

 Gross margin excluding depreciation and amortization

    617       1,934       898       991       4,440  

 Cash operating coverage ratio (%)

                                    68  

 

17


Retail Adjusted Average Working Capital to Sales and Retail Adjusted Average Working Capital to Sales Excluding Nutrien Financial

Definition: Retail adjusted average working capital divided by Retail adjusted sales for the last four rolling quarters. We exclude in our calculations the sales and working capital of certain acquisitions during the first year following the acquisition. We also look at this metric excluding Nutrien Financial revenue and working capital.

Why we use the measure and why it is useful to investors: To evaluate operational efficiency. A lower or higher percentage represents increased or decreased efficiency, respectively. The metric excluding Nutrien Financial shows the impact that the working capital of Nutrien Financial has on the ratio.

 

    Rolling four quarters ended December 31, 2024  
 (millions of US dollars, except as otherwise noted)   Q1 2024     Q2 2024     Q3 2024     Q4 2024          Average/Total  

 Current assets

    11,821       11,181       10,559       10,360      

 Current liabilities

    (8,401     (8,002     (5,263     (8,028            

 Working capital

    3,420       3,179       5,296       2,332         3,557  

 Working capital from certain recent acquisitions

    -       -       -       -              

 Adjusted working capital

    3,420       3,179       5,296       2,332         3,557  

 Nutrien Financial working capital

    (2,489     (4,560     (4,318     (2,877            

 Adjusted working capital excluding Nutrien Financial

    931       (1,381     978       (545         (4

 Sales

    3,308       8,074       3,271       3,179      

 Sales from certain recent acquisitions

    -       -       -       -              

 Adjusted sales

    3,308       8,074       3,271       3,179         17,832  

 Nutrien Financial revenue

    (66     (133     (85     (77            

 Adjusted sales excluding Nutrien Financial

    3,242       7,941       3,186       3,102           17,471  

 Adjusted average working capital to sales (%)

              20  

 Adjusted average working capital to sales excluding Nutrien Financial (%)

 

        -  
    Rolling four quarters ended December 31, 2023  
 (millions of US dollars, except as otherwise noted)   Q1 2023     Q2 2023     Q3 2023     Q4 2023          Average/Total  

 Current assets

    13,000       11,983       10,398       10,498      

 Current liabilities

    (8,980     (8,246     (5,228     (8,210            

 Working capital

    4,020       3,737       5,170       2,288         3,804  

 Working capital from certain recent acquisitions

    -       -       -       -              

 Adjusted working capital

    4,020       3,737       5,170       2,288         3,804  

 Nutrien Financial working capital

    (2,283     (4,716     (4,353     (2,893            

 Adjusted working capital excluding Nutrien Financial

    1,737       (979     817       (605         243  

 Sales

    3,422       9,128       3,490       3,502      

 Sales from certain recent acquisitions

    -       -       -       -              

 Adjusted sales

    3,422       9,128       3,490       3,502         19,542  

 Nutrien Financial revenue

    (57     (122     (73     (70            

 Adjusted sales excluding Nutrien Financial

    3,365       9,006       3,417       3,432           19,220  

 Adjusted average working capital to sales (%)

              19  

 Adjusted average working capital to sales excluding Nutrien Financial (%)

 

        1  

 

18


Other Financial Measures

Selected Additional Financial Data

 

 Nutrien Financial    As at December 31, 2024     

As at

December 31,
2023

 
 (millions of US dollars)    Current     

<31 Days

Past Due

    

31–90
Days

Past Due

    

>90 Days

Past Due

     Gross
Receivables
     Allowance 1      Net
Receivables
     Net
Receivables
 

 North America

     1,671        289        112        156        2,228        (50      2,178        2,206  

 International

     575        51        19        64        709        (10      699        687  

 Nutrien Financial receivables

     2,246        340        131        220        2,937        (60      2,877        2,893  

1  Bad debt expense on the above receivables for the twelve months ended December 31, 2024 and 2023 were $55 million and $35 million, respectively, in the Retail segment.

Supplementary Financial Measures

Supplementary financial measures are financial measures disclosed by the Company that (a) are, or are intended to be, disclosed on a periodic basis to depict the historical or expected future financial performance, financial position or cash flow of the Company, (b) are not disclosed in the financial statements of the Company, (c) are not non-GAAP financial measures, and (d) are not non-GAAP ratios.

The following section provides an explanation of the composition of those supplementary financial measures, if not previously provided.

Sustaining capital expenditures: Represents capital expenditures that are required to sustain operations at existing levels and include major repairs and maintenance and plant turnarounds.

Investing capital expenditures: Represents capital expenditures related to significant expansions of current operations or to create cost savings (synergies). Investing capital expenditures excludes capital outlays for business acquisitions and equity-accounted investees.

Mine development and pre-stripping capital expenditures: Represents capital expenditures that are required for activities to open new areas underground and/or develop a mine or ore body to allow for future production mining and activities required to prepare and/or access the ore, i.e., removal of an overburden that allows access to the ore.

Cash used for dividends and share repurchases: Calculated as dividends paid to Nutrien’s shareholders plus repurchase of common shares as reflected in the unaudited condensed consolidated statements of cash flows. This measure is useful as it represents return of capital to shareholders.

 

19


Unaudited  

 

Condensed Consolidated Financial Statements

Condensed Consolidated Statements of Earnings

 

           Three Months Ended
December 31
    Twelve Months Ended
December 31
 
 (millions of US dollars, except as otherwise noted)    Note     2024     2023     2024     2023  

 SALES

     2, 10       5,079       5,664       25,972       29,056  

 Freight, transportation and distribution

       215       260       956       974  

 Cost of goods sold

             3,283       3,636       17,486       19,608  

 GROSS MARGIN

       1,581       1,768       7,530       8,474  

 Selling expenses

       813       849       3,435       3,397  

 General and administrative expenses

       176       173       644       626  

 Provincial mining taxes

       45       79       255       398  

 Share-based compensation expense (recovery)

       20       (7     37       (14

 Impairment of assets

     3       -       76       530       774  

 Foreign exchange loss (gain), net of related derivatives

     6       1       (14     360       91  

 Other expenses

     4       129       319       413       457  

 EARNINGS BEFORE FINANCE COSTS AND INCOME TAXES

 

    397       293       1,856       2,745  

 Finance costs

             195       213       720       793  

 EARNINGS BEFORE INCOME TAXES

       202       80       1,136       1,952  

 Income tax expense (recovery)

     5       84       (96     436       670  

 NET EARNINGS

             118       176       700       1,282  

 Attributable to

          

 Equity holders of Nutrien

       113       172       674       1,258  

 Non-controlling interest

             5       4       26       24  

 NET EARNINGS

             118       176       700       1,282  

 NET EARNINGS PER SHARE ATTRIBUTABLE TO EQUITY HOLDERS OF NUTRIEN (“EPS”)

 

               

 Basic

       0.23       0.35       1.36       2.53  

 Diluted

             0.23       0.35       1.36       2.53  

 Weighted average shares outstanding for basic EPS

       492,843,000       494,545,000       494,198,000       496,381,000  

 Weighted average shares outstanding for diluted EPS

             492,930,000       494,878,000       494,365,000       496,994,000  
Condensed Consolidated Statements of Comprehensive (Loss) Income

 

         Three Months Ended
December 31
    Twelve Months Ended
December 31
 
 (millions of US dollars, net of related income taxes)           2024     2023     2024     2023  

 NET EARNINGS

       118       176       700       1,282  

 Other comprehensive (loss) income

          

 Items that will not be reclassified to net earnings:

          

 Net actuarial gain (loss) on defined benefit plans

       17       (14     17       (17

 Net fair value gain (loss) on investments

       2       (1     55       4  

 Items that have been or may be subsequently reclassified to net earnings:

          

 (Loss) gain on currency translation of foreign operations

       (282     103       (254     89  

 Other

             (35     9       (52     5  

 OTHER COMPREHENSIVE (LOSS) INCOME

             (298     97       (234     81  

 COMPREHENSIVE (LOSS) INCOME

             (180     273       466       1,363  

 Attributable to

          

 Equity holders of Nutrien

       (182     268       443       1,338  

 Non-controlling interest

             2       5       23       25  

 COMPREHENSIVE (LOSS) INCOME

             (180     273       466       1,363  

(See Notes to the Condensed Consolidated Financial Statements)

 

20


Unaudited  

 

Condensed Consolidated Statements of Cash Flows

 

            Three Months Ended
December 31
     Twelve Months Ended
December 31
 
 (millions of US dollars)    Note      2024      2023      2024      2023  
                   Note 1             Note 1  

 OPERATING ACTIVITIES

              

 Net earnings

        118        176        700        1,282  

 Adjustments for:

              

 Depreciation and amortization

        590        565        2,339        2,169  

 Share-based compensation expense (recovery)

        20        (7      37        (14

 Impairment of assets

     3        -        76        530        774  

 Provision for (recovery of) deferred income tax

        16        (169      31        7  

 Net (undistributed) distributed earnings of equity-accounted investees

        (22      5        (8      117  

 Loss related to financial instruments in Argentina

     4        1        -        35        92  

 Long-term income tax receivables and payables

        30        24        47        (65

 Other long-term assets, liabilities and miscellaneous

              (16      153        311        197  

 Cash from operations before working capital changes

        737        823        4,022        4,559  

 Changes in non-cash operating working capital:

              

 Receivables

        2,170        2,370        (224      879  

 Inventories and prepaid expenses and other current assets

        (2,205      (1,990      60        1,376  

 Payables and accrued charges

              2,421        2,947        (323      (1,748

 CASH PROVIDED BY OPERATING ACTIVITIES

              3,123        4,150        3,535        5,066  

 INVESTING ACTIVITIES

              

 Capital expenditures 1

        (767      (760      (2,154      (2,600

 Business acquisitions, net of cash acquired

        (15      (37      (21      (153

 Proceeds from (purchase of) investments, held within three months, net

        74        22        44        (112

 Purchase of investments

        -        (19      (112      (31

 Net changes in non-cash working capital

        82        46        27        (22

 Other

              107        15        83        (40

 CASH USED IN INVESTING ACTIVITIES

              (519      (733      (2,133      (2,958

 FINANCING ACTIVITIES

              

 Repayment of debt, maturing within three months, net

        (1,231      (2,671      (142      (458

 Proceeds from debt

     8        24        -        1,022        1,500  

 Repayment of debt

     8        (527      (13      (659      (648

 Repayment of principal portion of lease liabilities

        (102      (97      (402      (375

 Dividends paid to Nutrien’s shareholders

     9        (265      (262      (1,060      (1,032

 Repurchase of common shares, inclusive of related tax

     9        (134      -        (184      (1,047

 Issuance of common shares

        2        1        18        33  

 Other

              (6      -        (46      (34

 CASH USED IN FINANCING ACTIVITIES

              (2,239      (3,042      (1,453      (2,061

 EFFECT OF EXCHANGE RATE CHANGES ON CASH AND
CASH EQUIVALENTS

              (32      12        (37      (7

 INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS

        333        387        (88      40  

 CASH AND CASH EQUIVALENTS – BEGINNING OF PERIOD

              520        554        941        901  

 CASH AND CASH EQUIVALENTS – END OF PERIOD

              853        941        853        941  

 Cash and cash equivalents is composed of:

              

 Cash

                741                909                741                909  

 Short-term investments

              112        32        112        32  
                853        941        853        941  

 SUPPLEMENTAL CASH FLOWS INFORMATION

              

 Interest paid

        244        267        740        729  

 Income taxes paid

        61        42        321        1,764  

 Total cash outflow for leases

              140        128        558        501  

1  Includes additions to property, plant and equipment, and intangible assets for the three months ended December 31, 2024 of $735 million and $32 million (2023 – $716 million and $44 million), respectively, and for the twelve months ended December 31, 2024 of $2,025 million and $129 million (2023 – $2,415 million and $185 million), respectively.

(See Notes to the Condensed Consolidated Financial Statements)

 

21


Unaudited  

Condensed Consolidated Statements of Changes in Shareholders’ Equity

 

                      Accumulated Other Comprehensive
(Loss) Income (“AOCI”)
                         
 (millions of US dollars, inclusive of related tax, except as
otherwise noted)
  Number of
Common
Shares
    Share
Capital
    Contributed
Surplus
    (Loss) Gain
on Currency
Translation
of Foreign
Operations
    Other     Total
AOCI
    Retained
Earnings
    Equity
Holders
of
Nutrien
    Non-
Controlling
Interest
    Total
Equity
 
           

 BALANCE – DECEMBER 31, 2022

    507,246,105       14,172       109       (374     (17     (391     11,928       25,818       45       25,863  
           

 Net earnings

    -       -       -       -       -       -       1,258       1,258       24       1,282  
           

 Other comprehensive income (loss)

    -       -       -       88       (8     80       -       80       1       81  
           

 Shares repurchased (Note 9)

    (13,378,189     (374     (26     -       -       -       (600     (1,000     -       (1,000
           

 Dividends declared - $2.12/share

    -       -       -       -       -       -       (1,050     (1,050     -       (1,050
           

 Non-controlling interest transactions

    -       -       -       -       -       -       (2     (2     (25     (27
           

 Effect of share-based compensation including issuance of common shares

    683,814       40       -       -       -       -       -       40       -       40  
           

 Transfer of net gain on sale of investment

    -       -       -       -       (14     (14     14       -       -       -  
           

 Transfer of net loss on cash flow hedges

    -       -       -       -       12       12       -       12       -       12  
           

 Transfer of net actuarial loss on defined benefit plans

    -       -       -       -       17       17       (17     -       -       -  
           

 BALANCE – DECEMBER 31, 2023

    494,551,730       13,838       83       (286     (10     (296     11,531       25,156       45       25,201  
           

 Net earnings

    -       -       -       -       -       -       674       674       26       700  
           

 Other comprehensive (loss) income

    -       -       -       (251     20       (231     -       (231     (3     (234
           

 Shares repurchased (Note 9)

    (3,944,903     (110     (20     -       -       -       (60     (190     -       (190
           

 Dividends declared - $2.16/share

    -       -       -       -       -       -       (1,063     (1,063     -       (1,063
           

 Non-controlling interest transactions

    -       -       -       -       -       -       -       -       (33     (33
           

 Effect of share-based compensation including issuance of common shares

    418,619       20       5       -       -       -       -       25       -       25  
           

 Transfer of net gain on sale of investment

    -       -       -       -       -       -       7       7       -       7  
           

 Transfer of net loss on cash flow hedges

    -       -       -       -       29       29       -       29       -       29  
           

 Transfer of net actuarial gain on defined benefit plans

    -       -       -       -       (17     (17     17       -       -       -  
         

 BALANCE – DECEMBER 31, 2024

    491,025,446       13,748       68       (537     22       (515     11,106       24,407       35       24,442  

(See Notes to the Condensed Consolidated Financial Statements)

 

22


Unaudited  

 

Condensed Consolidated Balance Sheets

 

                December 31      December 31  
 As at (millions of US dollars)    Note               2024          2023  

 ASSETS

          

 Current assets

          

Cash and cash equivalents

          853        941  

Receivables

   6, 7, 10        5,390        5,398  

Inventories

          6,148        6,336  

Prepaid expenses and other current assets

                  1,401        1,495  
          13,792        14,170  

 Non-current assets

          

Property, plant and equipment

   3        22,604        22,461  

Goodwill

   3        12,043        12,114  

Intangible assets

   3        1,819        2,217  

Investments

          698        736  

Other assets

                  884        1,051  

 TOTAL ASSETS

                  51,840        52,749  

 LIABILITIES

          

 Current liabilities

          

Short-term debt

   7        1,534        1,815  

Current portion of long-term debt

   8        1,037        512  

Current portion of lease liabilities

          356        327  

Payables and accrued charges

   6              9,118        9,467  
          12,045        12,121  

 Non-current liabilities

          

Long-term debt

   8        8,881        8,913  

Lease liabilities

          999        999  

Deferred income tax liabilities

          3,539        3,574  

Pension and other post-retirement benefit liabilities

          227        252  

Asset retirement obligations and accrued environmental costs

          1,543        1,489  

Other non-current liabilities

                  164        200  

 TOTAL LIABILITIES

                  27,398        27,548  

 SHAREHOLDERS’ EQUITY

          

Share capital

   9        13,748        13,838  

Contributed surplus

          68        83  

Accumulated other comprehensive loss

          (515      (296

Retained earnings

                  11,106        11,531  

Equity holders of Nutrien

          24,407        25,156  

Non-controlling interest

                  35        45  

 TOTAL SHAREHOLDERS’ EQUITY

                  24,442        25,201  

 TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY

                  51,840        52,749  

(See Notes to the Condensed Consolidated Financial Statements)

 

23


Unaudited  

 

Notes to the Condensed Consolidated Financial Statements

As at and for the Three and Twelve Months Ended December 31, 2024

Note 1 Basis of presentation

Nutrien Ltd. (collectively with its subsidiaries, “Nutrien”, “we”, “us”, “our” or “the Company”) is a leading global provider of crop inputs and services. We operate a world-class network of production, distribution and ag retail facilities that positions us to efficiently serve the needs of farmers.

These unaudited interim condensed consolidated financial statements (“interim financial statements”) are based on International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board and have been prepared in accordance with IAS 34, “Interim Financial Reporting”. The accounting policies and methods of computation used in preparing these interim financial statements are materially consistent with those used in the preparation of our 2023 annual audited consolidated financial statements, as well as any amended standards adopted in 2024 that we previously disclosed. These interim financial statements include the accounts of Nutrien and its subsidiaries; however, they do not include all disclosures normally provided in annual audited consolidated financial statements and should be read in conjunction with our 2023 annual audited consolidated financial statements.

Certain immaterial 2023 figures have been reclassified in the condensed consolidated statements of earnings, condensed consolidated statements of cash flows and Note 4 Other expenses.

In management’s opinion, the interim financial statements include all adjustments necessary to fairly present such information in all material respects. Interim results are not necessarily indicative of the results expected for any other interim period or the fiscal year.

These interim financial statements were authorized by the Audit Committee of the Board of Directors for issue on February 19, 2025.

Note 2 Segment information

We have four reportable operating segments: Nutrien Ag Solutions (“Retail”), Potash, Nitrogen and Phosphate. Our downstream Retail segment distributes crop nutrients, crop protection products, seed and merchandise, and provides agronomic application services and solutions, including the services offered through Nutrien Financial. Retail also manufactures and distributes proprietary products and provides services directly to farmers through a network of retail locations in North America, South America and Australia. Our upstream Potash, Nitrogen and Phosphate segments are differentiated by the chemical nutrient contained in the products that each segment produces and are supported by midstream activities, which include the global sales, freight, transportation and distribution of our products, which are reported within these segments, respectively. Potash freight, transportation and distribution costs only apply to our North American potash sales volumes. Sales reported under our Corporate and Others segment relates to our non-core business. EBITDA presented in the succeeding tables is calculated as net earnings (loss) before finance costs, income taxes, and depreciation and amortization.

 

     Downstream            Upstream and Midstream                      
 (millions of US dollars)    Retail             Potash      Nitrogen      Phosphate     

 

Corporate
and Others

     Eliminations     Consolidated  

 Assets – as at December 31, 2024

     22,149          13,792        11,603        2,453        2,571        (728     51,840  

 Assets – as at December 31, 2023

     23,056                13,571        11,466        2,438        2,818        (600     52,749  

 

24


Unaudited  

 

    Three Months Ended December 31, 2024  
    Downstream           Upstream and Midstream                    
 (millions of US dollars)   Retail            Potash     Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales  – third party

    3,179         522       953       403       22       -       5,079  

        – intersegment

    -               65       223       68       -       (356     -  

 Sales  – total

    3,179         587       1,176       471       22       (356     5,079  

 Freight, transportation and distribution

    -               51       163       57       -       (56     215  

 Net sales

    3,179         536       1,013       414       22       (300     4,864  

 Cost of goods sold

    2,193               309       700       394       9       (322     3,283  

 Gross margin

    986         227       313       20       13       22       1,581  

 Selling expenses (recovery)

    808         1       3       1       7       (7     813  

 General and administrative expenses

    37         2       8       3       126       -       176  

 Provincial mining taxes

    -         45       -       -       -       -       45  

 Share-based compensation expense

    -         -       -       -       20       -       20  

 Foreign exchange loss, net of related derivatives

    -         -       -       -       1       -       1  

 Other (income) expenses

    (8             22       1       7       105       2       129  

 Earnings (loss) before finance costs and income taxes

    149         157       301       9       (246     27       397  

 Depreciation and amortization

    191               134       170       77       18       -       590  

 EBITDA

    340         291       471       86       (228     27       987  

 Restructuring costs

    -         -       -       -       47       -       47  

 Share-based compensation expense

    -         -       -       -       20       -       20  

 Loss related to financial instruments in Argentina

    -         -       -       -       1       -       1  

 ARO/ERL related expense for non-operating sites

    -         -       -       -       (1     -       (1

 Foreign exchange loss, net of related derivatives

    -               -       -       -       1       -       1  

 Adjusted EBITDA

    340               291       471       86       (160     27       1,055  

 

25


Unaudited  

 

    Three Months Ended December 31, 2023  
    Downstream           Upstream and Midstream                    
 (millions of US dollars)   Retail            Potash     Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales  – third party

    3,504         734       895       531       -       -       5,664  

        – intersegment

    (2             129       223       84       -       (434     -  

 Sales  – total

    3,502         863       1,118       615       -       (434     5,664  

 Freight, transportation and distribution

    -               87       162       82       -       (71     260  

 Net sales

    3,502         776       956       533       -       (363     5,404  

 Cost of goods sold

    2,513               349       671       463       -       (360     3,636  

 Gross margin

    989         427       285       70       -       (3     1,768  

 Selling expenses (recovery)

    841         3       4       1       7       (7     849  

 General and administrative expenses

    55         3       10       1       104       -       173  

 Provincial mining taxes

    -         79       -       -       -       -       79  

 Share-based compensation recovery

    -         -       -       -       (7     -       (7

 Impairment of assets

    -         -       76       -       -       -       76  

 Foreign exchange gain, net of related derivatives

    -         -       -       -       (14     -       (14

 Other expenses (income)

    77               (3     26       19       175       25       319  

 Earnings (loss) before finance costs and income taxes

    16         345       169       49       (265     (21     293  

 Depreciation and amortization

    201               118       146       81       19       -       565  

 EBITDA

    217         463       315       130       (246     (21     858  

 Restructuring costs

    12         -       -       -       8       -       20  

 Share-based compensation recovery

    -         -       -       -       (7     -       (7

 Impairment of assets

    -         -       76       -       -       -       76  

 ARO/ERL related expense for non-operating sites

    -         -       -       -       142       -       142  

 Foreign exchange gain, net of related derivatives

    -               -       -       -       (14     -       (14

 Adjusted EBITDA

    229               463       391       130       (117     (21     1,075  

 

26


Unaudited  

 

    Twelve Months Ended December 31, 2024  
    Downstream            Upstream and Midstream                     
 (millions of US dollars)   Retail             Potash      Nitrogen     Phosphate      Corporate
and Others
    Eliminations     Consolidated  

 Sales  – third party

    17,832          3,008        3,500       1,610        22       -       25,972  

     – intersegment

    -                370        807       278        -       (1,455     -  

 Sales  – total

    17,832          3,378        4,307       1,888        22       (1,455     25,972  

 Freight, transportation and distribution

    -                389        562       231        -       (226     956  

 Net sales

    17,832          2,989        3,745       1,657        22       (1,229     25,016  

 Cost of goods sold

    13,211                1,448        2,535       1,510        9       (1,227     17,486  

 Gross margin

    4,621          1,541        1,210       147        13       (2     7,530  

 Selling expenses (recovery)

    3,418          10        26       6        -       (25     3,435  

 General and administrative expenses

    191          12        24       14        403       -       644  

 Provincial mining taxes

    -          255        -       -        -       -       255  

 Share-based compensation expense

    -          -        -       -        37       -       37  

 Impairment of assets

    335          -        195       -        -       -       530  

 Foreign exchange loss, net of related derivatives

    -          -        -       -        360       -       360  

 Other expenses (income)

    87                25        (135     33        379       24       413  

 Earnings (loss) before finance costs and income taxes

    590          1,239        1,100       94        (1,166     (1     1,856  

 Depreciation and amortization

    771                609        589       290        80       -       2,339  

 EBITDA

    1,361          1,848        1,689       384        (1,086     (1     4,195  

 Restructuring costs

    -          -        -       -        47       -       47  

 Share-based compensation expense

    -          -        -       -        37       -       37  

 Impairment of assets

    335          -        195       -        -       -       530  

 Loss related to financial instruments in Argentina

    -          -        -       -        35       -       35  

 ARO/ERL related expense for non-operating sites 

    -          -        -       -        151       -       151  

 Foreign exchange loss, net of related derivatives

    -                -        -       -        360       -       360  

 Adjusted EBITDA

    1,696                1,848        1,884       384        (456     (1     5,355  

 

27


Unaudited  

 

    Twelve Months Ended December 31, 2023  
    Downstream            Upstream and Midstream                    
(millions of US dollars)   Retail             Potash     Nitrogen     Phosphate     Corporate
and Others
    Eliminations     Consolidated  

 Sales  – third party

    19,542          3,735       3,804       1,975       -       -       29,056  

     – intersegment

    -                431       931       288       -       (1,650     -  

 Sales  – total

    19,542          4,166       4,735       2,263       -       (1,650     29,056  

 Freight, transportation and distribution

    -                407       528       270       -       (231     974  

 Net sales

    19,542          3,759       4,207       1,993       -       (1,419     28,082  

 Cost of goods sold

    15,112                1,396       2,828       1,760       -       (1,488     19,608  

 Gross margin

    4,430          2,363       1,379       233       -       69       8,474  

 Selling expenses (recovery)

    3,375          12       27       6       -       (23     3,397  

 General and administrative expenses

    217          13       21       11       364       -       626  

 Provincial mining taxes

    -          398       -       -       -       -       398  

 Share-based compensation recovery

    -          -       -       -       (14     -       (14

 Impairment of assets

    465          -       76       233       -       -       774  

 Foreign exchange loss, net of related derivatives

    -          -       -       -       91       -       91  

 Other expenses (income)

    158                (1     (27     40       257       30       457  

 Earnings (loss) before finance costs and income taxes

    215          1,941       1,282       (57     (698     62       2,745  

 Depreciation and amortization

    759                463       572       294       81       -       2,169  

 EBITDA

    974          2,404       1,854       237       (617     62       4,914  

 Restructuring costs

    20          -       -       -       29       -       49  

 Share-based compensation recovery

    -          -       -       -       (14     -       (14

 Impairment of assets

    465          -       76       233       -       -       774  

 Loss related to financial instruments in Argentina

    -          -       -       -       92       -       92  

 ARO/ERL related expense for non-operating sites

    -          -       -       -       152       -       152  

 Foreign exchange loss, net of related derivatives

    -                -       -       -       91       -       91  

 Adjusted EBITDA

    1,459                2,404       1,930       470       (267     62       6,058  

 

28


Unaudited  

 

    Three Months Ended
December 31
    Twelve Months Ended
December 31
 
 (millions of US dollars)   2024     2023     2024     2023  

 Retail sales by product line

       

Crop nutrients

    1,528       1,808       7,211       8,379  

Crop protection products

    948       960       6,313       6,750  

Seed

    184       202       2,235       2,295  

Services and other

    228       236       918       927  

Merchandise

    230       251       897       1,001  

Nutrien Financial

    77       70       361       322  

Nutrien Financial elimination 1

    (16     (25     (103     (132
      3,179       3,502       17,832       19,542  

 Potash sales by geography

       

Manufactured product

       

North America

    245       459       1,719       2,090  

Offshore 2

    342       404       1,658       2,076  

Other potash and purchased products

    -       -       1       -  
      587       863       3,378       4,166  

 Nitrogen sales by product line

       

Manufactured product

       

Ammonia

    376       339       1,232       1,337  

Urea and ESN®

    395       346       1,480       1,624  

Solutions, nitrates and sulfates

    339       345       1,300       1,367  

Other nitrogen and purchased products

    66       88       295       407  
      1,176       1,118       4,307       4,735  

 Phosphate sales by product line

       

Manufactured product

       

Fertilizer

    309       378       1,237       1,264  

Industrial and feed

    157       168       627       703  

Other phosphate and purchased products

    5       69       24       296  
      471       615       1,888       2,263  

1  Represents elimination of the interest and service fees charged by Nutrien Financial to Retail branches.

2  Relates to Canpotex Limited (“Canpotex”) (see Note 10) and includes provisional pricing adjustments for the three months ended December 31, 2024 of $(3) million (2023 – $(40) million) and the twelve months ended December 31, 2024 of $4 million (2023 – $(394) million).

Note 3 Impairment of assets

We recorded the following non-cash impairment of assets in the condensed consolidated statements of earnings:

 

         Three Months Ended
December 31
    Twelve Months Ended
December 31
 
 (millions of US dollars)         2024     2023     2024     2023  

 Segment

   Category        

 Retail

   Intangible assets     -       -       200       43  
   Property, plant and equipment     -       -       120       -  
   Other     -       -       15       -  
   Goodwill     -       -       -       422  

 Nitrogen

   Property, plant and equipment     -       76       195       76  

 Phosphate

  

Property, plant and equipment

    -       -       -       233  

 Impairment of assets

    -        76        530        774  

Retail – Brazil

During the three months ended June 30, 2024, due to the ongoing market instability and more moderate margin expectations, we lowered our forecasted EBITDA for the Retail – Brazil cash generating unit (“CGU”). This triggered an impairment analysis.

 

29


Unaudited  

 

We used the fair value less cost to dispose (“FVLCD”) methodology (Level 3) based on a market approach using the sales comparison method to assess the recoverable value of the Retail – Brazil CGU at June 30, 2024. This is a change from the methodology used in our 2023 analysis, as the market approach resulted in a more representative fair value of the CGU as restructuring initiatives in Brazil are currently being developed. In 2023, we used the FVLCD methodology based on after-tax discounted cash flows (10-year projections plus a terminal value) and an after-tax discount rate (14.4 percent). In 2024, we incorporated assumptions that an independent market participant would apply.

 

 (millions of US dollars)    Retail – Brazil
June 30, 2024
 

 Recoverable amount comprised of:

  

Working capital and other

     324  

Property, plant and equipment

     92  

Intangible assets

     -  

The key assumptions with the greatest influence on the calculation of the impairment are the estimated recoverable value of property, plant and equipment and intangible assets. Any change to these estimates could directly impact the impairment amount.

Nitrogen

During the three months ended June 30, 2024, we decided that we are no longer pursuing our Geismar Clean Ammonia project. As a result, we recorded an impairment loss of $195 million to fully write off the amount of property, plant and equipment related to this project. As the project was cancelled before it generated revenue, the recoverable amount, which was based on its value in use was $nil.

Goodwill Impairment Testing

 

 As at December 31 (millions of US dollars)        2024         2023  

 Goodwill by CGU or Group of CGUs

    

 Retail – North America

     6,961       6,981  

 Retail – Australia

     539       590  

 Potash

     154       154  

 Nitrogen

     4,389       4,389  
       12,043        12,114  

During the three and twelve months ended December 31, 2024, we performed our annual impairment test on goodwill and did not identify any impairment.

In testing for impairment of goodwill, we calculate the recoverable amount for a CGU or groups of CGUs containing goodwill. We used the FVLCD methodology based on after-tax discounted cash flows (five-year projections plus a terminal value) and incorporated assumptions an independent market participant would apply. We adjusted discount rates for each CGU or group of CGUs for the risk associated with achieving our forecasts and for the country risk premium in which we expect to generate cash flows. FVLCD is a Level 3 measurement. We use our market capitalization (where applicable) and comparative market multiples to ensure discounted cash flow results are reasonable.

The key assumptions with the greatest influence on the calculation of the recoverable amounts are the discount rates, terminal growth rates and forecasted EBITDA. The key forecast assumptions were based on historical data and our estimates of future results from internal sources considering industry and market information.

During our performance of our annual impairment test, the Retail – North America group of CGUs recoverable amount exceeded its carrying amount by $2.8 billion. Goodwill is more susceptible to impairment risk if there is an increase in the discount rate or a deterioration in business operating results or economic conditions and actual results do not meet our forecasts. A reduction in the terminal growth rate, an increase in the discount rate or a decrease in forecasted EBITDA could cause impairment in the future as shown in the table below.

 

 2024 Annual Impairment Testing    Key Assumption
Used in Impairment Model
     Change Required for Carrying Amount
to Equal Recoverable Amount

 Terminal growth rate (%)

     2.5        1.4      Percentage point decrease

 Discount rate 1 (%)

     7.3        1.1      Percentage point increase

 Forecasted EBITDA over forecast period ($ millions)

     8,300           11.1      Percent decrease

1  The discount rate used in the previous measurement at October 1, 2023 was 8.6 percent. At December 31, 2024, the discount rate was 8.0 percent.

 

30


Unaudited  

 

The following table indicates the key assumptions used in testing the remaining groups of CGUs:

 

     Terminal Growth Rate (%)      Discount Rate (%)  
          2024          2023          2024          2023  

 Retail – Australia

     2.6        2.1        7.9        9.0  

 Potash

     2.5        2.5        6.3        7.6  

 Nitrogen

     2.3        2.3        7.6        8.3  

Note 4 Other expenses (income)

 

     Three Months Ended
December 31
     Twelve Months Ended
December 31
 
 (millions of US dollars)        2024          2023          2024          2023  

 Restructuring costs

     47        20        47        49  

 Earnings of equity-accounted investees

     (23      (1      (130      (101

 Bad debt expense

     23        4        117        55  

 Project feasibility costs

     26        39        92        92  

 Customer prepayment costs

     12        12        58        55  

 Legal expenses

     15        16        47        34  

 Consulting expenses

     3        3        10        21  

 Insurance recoveries

     (3      -        (65      -  

 Loss on natural gas derivatives not designated as hedge

     1        -        8        -  

 Loss related to financial instruments in Argentina

     1        -        35        92  

 ARO/ERL related (income) expenses for non-operating sites ¹

     (1      142        151        152  

 Gain on amendments to other post-retirement pension plans

     -        -        -        (80

 Other expenses

     28        84        43        88  
       129        319        413        457  

1  ARO/ERL refers to asset retirement obligations and accrued environmental costs.

Argentina has certain currency controls in place that limit our ability to settle our foreign currency-denominated obligations or remit cash out of Argentina. We utilize various financial instruments such as Blue Chip Swaps or Bonds for the Reconstruction of a Free Argentina (“BOPREAL”) that effectively allow companies to transact in US dollars. We incurred losses on these transactions due to the significant divergence between the market exchange rate used for these financial instruments and the official Central Bank of Argentina rate. These losses are recorded as part of loss related to financial instruments in Argentina.

Note 5 Income taxes

 

     Three Months Ended
December 31
     Twelve Months Ended
December 31
 
 (millions of US dollars, except as otherwise noted)        2024          2023          2024          2023  

 Actual effective tax rate on earnings (%)

     33        39        40        33  

 Actual effective tax rate including discrete items (%)

     42        (120      38        34  

 Discrete tax adjustments that impacted the tax rate

     18        (127      (13      28  

 

31


Unaudited  

 

Note 6 Financial instruments

Foreign Currency Derivatives

 

     Three Months Ended
December 31
    Twelve Months Ended
December 31
 
 (millions of US dollars)        2024         2023         2024          2023   

 Foreign exchange (gain) loss

     (13     (22     14        (10

 Hyperinflationary loss

     12       36       97        114  

 Loss (gain) on foreign currency derivatives at fair value through profit or loss

     2       (28     249        (13

 Foreign exchange loss (gain), net of related derivatives

     1       (14     360        91  

For the twelve months ended December 31, 2024, the losses on our foreign currency derivatives were primarily related to Brazil which matured in July 2024. As of December 31, 2024, outstanding derivative contracts were related to our ongoing risk management strategy. The fair value of our net foreign exchange currency derivative (liabilities) assets as at December 31, 2024 was $(13) million (December 31, 2023 – $11 million).

Natural Gas Derivatives

In 2024, we increased our use of natural gas derivatives to lock-in commodity prices. Our risk management strategies and accounting policies for derivatives that are designated and qualify as cash flow hedges are consistent with those disclosed in Note 10 and Note 30 of our 2023 annual consolidated financial statements, respectively. For derivatives that do not qualify as cash flow hedges, any gains or losses are recorded in net earnings in the current period.

We assess whether our derivative hedging transactions are expected to be or were highly effective, both at the hedge’s inception and on an ongoing basis, in offsetting changes in fair values of hedged items.

 

Hedging Transaction  

     Measurement of Ineffectiveness           

Potential Sources of Ineffectiveness

New York Mercantile Exchange (“NYMEX”) natural gas hedges      Assessed on a prospective and retrospective basis using regression analyses     

Changes in:

• timing of forecast transactions

• volume delivered

• our credit risk or the credit risk of a counterparty

The fair value of our natural gas derivative assets (liabilities) as at December 31, 2024 was $1 million (December 31, 2023 - $(5) million).

Our financial instruments carrying amount are a reasonable approximation of their fair values, except for our long-term debt, including current portion, that has a carrying value of $9,918 million and fair value of $9,317 million as at December 31, 2024. There were no transfers between levels for financial instruments measured at fair value on a recurring basis.

Note 7 Short-term debt

In 2024, we entered into an uncommitted $500 million accounts receivable repurchase facility (the “repurchase facility”), where we may sell certain receivables from customers to a financial institution and agree to repurchase those receivables at a future date. When we draw under this repurchase facility, the receivables from customers remain on our condensed consolidated balance sheet as we control and retain substantially all of the risks and rewards associated with the receivables. As at December 31, 2024, there were no borrowings outstanding under this facility.

In 2024, we extended the term of our unsecured revolving term credit facility to September 3, 2025 and reduced the facility limit from $1,500 million to $750 million. We also extended the maturity of our $4,500 million unsecured revolving term facility to September 4, 2029.

 

32


Unaudited  

 

Note 8 Long-term debt

 

 (millions of US dollars, except as otherwise noted)    Rate of interest (%)         Maturity         Amount   

 Senior notes repaid in 2024

     5.9           November 7, 2024           500   

 Senior notes issued in 2024

     5.2           June 21, 2027           400   

 Senior notes issued in 2024

     5.4           June 21, 2034           600   
                             1,000   

The notes issued in the twelve months ended December 31, 2024, are unsecured, rank equally with our existing unsecured debt, and have no sinking fund requirements prior to maturity. Each series is redeemable and has various provisions for redemption prior to maturity, at our option, at specified prices.

In March 2024, we filed a base shelf prospectus in Canada and the US qualifying the issuance of common shares, debt securities and other securities during a period of 25 months from March 22, 2024.

Note 9 Share capital

Share Repurchase Programs

The following table summarizes our share repurchase activities during the periods indicated below:

 

     Three Months Ended
December 31
     Twelve Months Ended
December 31
 
  (millions of US dollars, except as otherwise noted)    2024       2023       2024       2023   

  Number of common shares repurchased for cancellation

     2,905,718         -         3,944,903         13,378,189   

  Average price per share (US dollars)

     47.02         -         47.31         74.73   

  Total cost, inclusive of tax

     139         -         190         1,000   

As of February 18, 2025, an additional 1,887,537 common shares were repurchased for cancellation at a cost of $96 million and an average price per share of $50.82.

On February 19, 2025, our Board of Directors approved a share repurchase program for up to five percent of our outstanding common shares. The 2025 normal course issuer bid, which is subject to the acceptance by the Toronto Stock Exchange, will expire after a one-year period, if we acquire the maximum number of common shares allowable or otherwise decide not to make any further repurchases.

Dividends Declared

We declared a dividend per share of $0.54 (2023 – $0.53) during the three months ended December 31, 2024, payable on January 17, 2025 to shareholders of record on December 31, 2024.

On February 19, 2025, our Board of Directors declared and increased our quarterly dividend to $0.545 per share payable on April 10, 2025, to shareholders of record on March 31, 2025. The total estimated dividend to be paid is $265 million.

 

33


Unaudited  

 

Note 10 Related party transactions

We sell potash outside Canada and the US exclusively through Canpotex. Our total revenue is recognized at the amount received from Canpotex representing proceeds from their sale of potash, less net costs of Canpotex. The receivable outstanding from Canpotex arose from sale transactions described above. It is unsecured and bears no interest. Any credit losses held against this receivable are expected to be negligible. Canpotex sells potash to buyers, including Nutrien, in export markets pursuant to term and spot contracts at agreed-upon prices. Purchases from Canpotex for the three months ended December 31, 2024 were $34 million (2023 – $32 million) and the twelve months ended December 31, 2024 were $146 million (2023 – $92 million).

 

 As at (millions of US dollars)      December 31, 2024         December 31, 2023   

 Receivables from Canpotex

     122         162   

 Payables to Canpotex

     66         64   

Note 11 Accounting policies, estimates and judgments

IFRS 18, “Presentation and Disclosure in Financial Statements” (“IFRS 18”), which was issued on April 9, 2024, would supersede IAS 1, “Presentation of Financial Statements” and increase the comparability of financial statements by enhancing principles on aggregation and disaggregation. IFRS 18 will be effective January 1, 2027, and will also apply to comparative information. We are reviewing the standard to determine the potential impact.

Amendments for IFRS 9 and IFRS 7, “Amendments to the Classification and Measurement of Financial Instruments”, which was issued on May 30, 2024, will address diversity in practice by making the requirements more understandable and consistently applied. These amendments will be effective January 1, 2026, and will not apply to comparative information. We are reviewing the standard to determine the potential impact.

 

34